文献检索文档翻译深度研究
Suppr Zotero 插件Zotero 插件
邀请有礼套餐&价格历史记录

新学期,新优惠

限时优惠:9月1日-9月22日

30天高级会员仅需29元

1天体验卡首发特惠仅需5.99元

了解详情
不再提醒
插件&应用
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
高级版
套餐订阅购买积分包
AI 工具
文献检索文档翻译深度研究
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2025

记忆性CD8 T细胞亚群的谱系关系及保护性免疫

Lineage relationship and protective immunity of memory CD8 T cell subsets.

作者信息

Wherry E John, Teichgräber Volker, Becker Todd C, Masopust David, Kaech Susan M, Antia Rustom, von Andrian Ulrich H, Ahmed Rafi

机构信息

Emory Vaccine Center and Department of Microbiology and Immunology, Emory University School of Medicine, Atlanta, GA 30322, USA.

出版信息

Nat Immunol. 2003 Mar;4(3):225-34. doi: 10.1038/ni889. Epub 2003 Feb 3.


DOI:10.1038/ni889
PMID:12563257
Abstract

Memory CD8 T cells can be divided into two subsets, central (T(CM)) and effector (T(EM)), but their lineage relationships and their ability to persist and confer protective immunity are not well understood. Our results show that T(CM) have a greater capacity than T(EM) to persist in vivo and are more efficient in mediating protective immunity because of their increased proliferative potential. We also demonstrate that, following antigen clearance, T(EM) convert to T(CM) and that the duration of this differentiation is programmed within the first week after immunization. We propose that T(CM) and T(EM) do not necessarily represent distinct subsets, but are part of a continuum in a linear naive --> effector --> T(EM) --> T(CM) differentiation pathway.

摘要

记忆性CD8 T细胞可分为两个亚群,即中枢性(T(CM))和效应性(T(EM)),但其谱系关系以及它们持续存在并赋予保护性免疫的能力尚未得到充分了解。我们的结果表明,T(CM)在体内持续存在的能力比T(EM)更强,并且由于其增殖潜力增加,在介导保护性免疫方面更有效。我们还证明,在抗原清除后,T(EM)会转化为T(CM),并且这种分化的持续时间在免疫后的第一周内就已编程。我们提出,T(CM)和T(EM)不一定代表不同的亚群,而是线性的幼稚→效应性→T(EM)→T(CM)分化途径中连续统一体的一部分。

相似文献

[1]
Lineage relationship and protective immunity of memory CD8 T cell subsets.

Nat Immunol. 2003-3

[2]
Unidirectional development of CD8+ central memory T cells into protective Listeria-specific effector memory T cells.

Eur J Immunol. 2006-6

[3]
Strength of stimulus and clonal competition impact the rate of memory CD8 T cell differentiation.

J Immunol. 2007-11-15

[4]
Simultaneous assessment of antigen-stimulated cytokine production and memory subset composition of memory CD8 T cells.

J Immunol Methods. 2006-6-30

[5]
Differences in the transduction of canonical Wnt signals demarcate effector and memory CD8 T cells with distinct recall proliferation capacity.

J Immunol. 2014-9-15

[6]
Programmed contraction of CD8(+) T cells after infection.

Nat Immunol. 2002-7

[7]
Monocyte-Derived Dendritic Cells Dictate the Memory Differentiation of CD8 T Cells During Acute Infection.

Front Immunol. 2019-8-16

[8]
Immune memory-boosting dose of rapamycin impairs macrophage vesicle acidification and curtails glycolysis in effector CD8 cells, impairing defense against acute infections.

J Immunol. 2014-7-15

[9]
Inhibitory signaling sustains a distinct early memory CD8 T cell precursor that is resistant to DNA damage.

Sci Immunol. 2021-1-15

[10]
Selective expression of the interleukin 7 receptor identifies effector CD8 T cells that give rise to long-lived memory cells.

Nat Immunol. 2003-12

引用本文的文献

[1]
Transcription factor BACH2 shapes tissue-resident memory T cell programs to promote HIV-1 persistence.

Immunity. 2025-8-16

[2]
Predictors of patients with advanced pancreatic cancer undergoing conversion surgery via chemoimmunotherapy with a multifunctional Wilms' tumor 1 (WT1) peptide cocktail-pulsed dendritic cell vaccine.

J Immunother Cancer. 2025-7-31

[3]
Central memory T cells with key TCR repertoires and gene expression profiles dominate influenza CD8+ T cell pools across the human lifespan.

Proc Natl Acad Sci U S A. 2025-7-29

[4]
ProS1-MerTK signaling in CD4 T cells: implications for TIL expansion and functionality.

Oncoimmunology. 2025-12

[5]
Elucidating the role of N-myristoylation in the excessive membrane localization of PD-L1 in hypoxic cancers and developing a novel NMT1 inhibitor for combination with immune checkpoint blockade therapy.

J Exp Clin Cancer Res. 2025-7-2

[6]
A 'two-missile' nanoplatform for targeting triple-negative breast cancer: prodrug activation and immune enhancement.

Mater Today Bio. 2025-5-20

[7]
A phase I/II trial of WT1-specific TCR gene therapy for patients with acute myeloid leukemia and active disease post-allogeneic hematopoietic cell transplantation: skewing towards NK-like phenotype impairs T cell function and persistence.

Nat Commun. 2025-6-5

[8]
Harnessing immunotherapeutic molecules and diagnostic biomarkers as human-derived adjuvants for MERS-CoV vaccine development.

Front Immunol. 2025-3-13

[9]
Developmental epigenetic programming by Tet1/3 determines peripheral CD8 T cell fate.

EMBO Rep. 2025-4-2

[10]
Severe malaria enforces short-lived effector cell differentiation but does not prevent effective secondary responses by memory CD8 T cells.

PLoS Pathog. 2025-3-31

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

推荐工具

医学文档翻译智能文献检索